Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Nanosonics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$3.17 |
52 Week High | AU$4.76 |
52 Week Low | AU$2.59 |
Beta | 1.49 |
11 Month Change | 0.63% |
3 Month Change | 13.62% |
1 Year Change | -25.41% |
33 Year Change | -52.69% |
5 Year Change | -54.97% |
Change since IPO | 286.59% |
Recent News & Updates
Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Shareholder Returns
NAN | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | 17.4% | -1.4% | 0.7% |
1Y | -25.4% | 9.9% | 10.5% |
Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 9.9% over the past year.
Return vs Market: NAN underperformed the Australian Market which returned 10.5% over the past year.
Price Volatility
NAN volatility | |
---|---|
NAN Average Weekly Movement | 8.6% |
Medical Equipment Industry Average Movement | 10.8% |
Market Average Movement | 8.4% |
10% most volatile stocks in AU Market | 17.4% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: NAN has not had significant price volatility in the past 3 months.
Volatility Over Time: NAN's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 466 | Michael Kavanagh | www.nanosonics.com.au |
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.
Nanosonics Limited Fundamentals Summary
NAN fundamental statistics | |
---|---|
Market cap | AU$978.68m |
Earnings (TTM) | AU$12.97m |
Revenue (TTM) | AU$170.01m |
74.0x
P/E Ratio5.6x
P/S RatioIs NAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NAN income statement (TTM) | |
---|---|
Revenue | AU$170.01m |
Cost of Revenue | AU$37.58m |
Gross Profit | AU$132.44m |
Other Expenses | AU$119.47m |
Earnings | AU$12.97m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.043 |
Gross Margin | 77.90% |
Net Profit Margin | 7.63% |
Debt/Equity Ratio | 0% |
How did NAN perform over the long term?
See historical performance and comparison